Cargando…

FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes

OBJECTIVE: Cardiovascular and renal complications contribute to higher mortality in patients with diabetes. We assessed novel and conventional predictors of mortality in African American–Diabetes Heart Study (AA-DHS) participants. RESEARCH DESIGN AND METHODS: Associations between mortality and subcl...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Gary C., Divers, Jasmin, Russell, Gregory B., Langefeld, Carl D., Wagenknecht, Lynne E., Hsu, Fang-Chi, Xu, Jianzhao, Smith, S. Carrie, Palmer, Nicholette D., Hicks, Pamela J., Bowden, Donald W., Register, Thomas C., Ma, Lijun, Carr, J. Jeffrey, Freedman, Barry I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741152/
https://www.ncbi.nlm.nih.gov/pubmed/29113983
http://dx.doi.org/10.2337/dc17-0820
_version_ 1783288151453728768
author Chan, Gary C.
Divers, Jasmin
Russell, Gregory B.
Langefeld, Carl D.
Wagenknecht, Lynne E.
Hsu, Fang-Chi
Xu, Jianzhao
Smith, S. Carrie
Palmer, Nicholette D.
Hicks, Pamela J.
Bowden, Donald W.
Register, Thomas C.
Ma, Lijun
Carr, J. Jeffrey
Freedman, Barry I.
author_facet Chan, Gary C.
Divers, Jasmin
Russell, Gregory B.
Langefeld, Carl D.
Wagenknecht, Lynne E.
Hsu, Fang-Chi
Xu, Jianzhao
Smith, S. Carrie
Palmer, Nicholette D.
Hicks, Pamela J.
Bowden, Donald W.
Register, Thomas C.
Ma, Lijun
Carr, J. Jeffrey
Freedman, Barry I.
author_sort Chan, Gary C.
collection PubMed
description OBJECTIVE: Cardiovascular and renal complications contribute to higher mortality in patients with diabetes. We assessed novel and conventional predictors of mortality in African American–Diabetes Heart Study (AA-DHS) participants. RESEARCH DESIGN AND METHODS: Associations between mortality and subclinical atherosclerosis, urine albumin–to–creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), plasma fibroblast growth factor 23 (FGF23) concentration, African ancestry proportion, and apolipoprotein L1 genotypes (APOL1) were assessed in 513 African Americans with type 2 diabetes; analyses were performed using Cox proportional hazards models. RESULTS: At baseline, participants were 55.6% female with median (25th, 75th percentile) age 55 years (49.0, 62.0), diabetes duration 8 years (5.0, 13.0), glycosylated hemoglobin 60.7 mmol/mol (48.6, 76.0), eGFR 91.3 mL/min/1.73 m(2) (76.4, 111.3), UACR 12.5 mg/mmol (4.2, 51.2), and coronary artery calcium 28.5 mg Ca(2+) (1.0, 348.6); 11.5% had two APOL1 renal-risk variants. After 6.6-year follow-up (5.8, 7.5), 54 deaths were recorded. Higher levels of coronary artery calcified plaque, carotid artery calcified plaque, albuminuria, and FGF23 were associated with higher mortality after adjustment for age, sex, and African ancestry proportion. A penalized Cox regression that included all covariates and predictors associated with mortality identified male sex (hazard ratio [HR] 4.17 [95% CI 1.96–9.09]), higher FGF23 (HR 2.10 [95% CI 1.59–2.78]), and absence of APOL1 renal-risk genotypes (HR 0.07 [95% CI 0.01–0.69]) as the strongest predictors of mortality. CONCLUSIONS: Accounting for conventional risk factors, higher FGF23 concentrations and APOL1 non–renal-risk genotypes associated with higher mortality in African Americans with diabetes. These data add to growing evidence supporting FGF23 association with mortality; mechanisms whereby these novel predictors impact survival remain to be determined.
format Online
Article
Text
id pubmed-5741152
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-57411522019-01-01 FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes Chan, Gary C. Divers, Jasmin Russell, Gregory B. Langefeld, Carl D. Wagenknecht, Lynne E. Hsu, Fang-Chi Xu, Jianzhao Smith, S. Carrie Palmer, Nicholette D. Hicks, Pamela J. Bowden, Donald W. Register, Thomas C. Ma, Lijun Carr, J. Jeffrey Freedman, Barry I. Diabetes Care Cardiovascular and Metabolic Risk OBJECTIVE: Cardiovascular and renal complications contribute to higher mortality in patients with diabetes. We assessed novel and conventional predictors of mortality in African American–Diabetes Heart Study (AA-DHS) participants. RESEARCH DESIGN AND METHODS: Associations between mortality and subclinical atherosclerosis, urine albumin–to–creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), plasma fibroblast growth factor 23 (FGF23) concentration, African ancestry proportion, and apolipoprotein L1 genotypes (APOL1) were assessed in 513 African Americans with type 2 diabetes; analyses were performed using Cox proportional hazards models. RESULTS: At baseline, participants were 55.6% female with median (25th, 75th percentile) age 55 years (49.0, 62.0), diabetes duration 8 years (5.0, 13.0), glycosylated hemoglobin 60.7 mmol/mol (48.6, 76.0), eGFR 91.3 mL/min/1.73 m(2) (76.4, 111.3), UACR 12.5 mg/mmol (4.2, 51.2), and coronary artery calcium 28.5 mg Ca(2+) (1.0, 348.6); 11.5% had two APOL1 renal-risk variants. After 6.6-year follow-up (5.8, 7.5), 54 deaths were recorded. Higher levels of coronary artery calcified plaque, carotid artery calcified plaque, albuminuria, and FGF23 were associated with higher mortality after adjustment for age, sex, and African ancestry proportion. A penalized Cox regression that included all covariates and predictors associated with mortality identified male sex (hazard ratio [HR] 4.17 [95% CI 1.96–9.09]), higher FGF23 (HR 2.10 [95% CI 1.59–2.78]), and absence of APOL1 renal-risk genotypes (HR 0.07 [95% CI 0.01–0.69]) as the strongest predictors of mortality. CONCLUSIONS: Accounting for conventional risk factors, higher FGF23 concentrations and APOL1 non–renal-risk genotypes associated with higher mortality in African Americans with diabetes. These data add to growing evidence supporting FGF23 association with mortality; mechanisms whereby these novel predictors impact survival remain to be determined. American Diabetes Association 2018-01 2017-11-07 /pmc/articles/PMC5741152/ /pubmed/29113983 http://dx.doi.org/10.2337/dc17-0820 Text en © 2017 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
spellingShingle Cardiovascular and Metabolic Risk
Chan, Gary C.
Divers, Jasmin
Russell, Gregory B.
Langefeld, Carl D.
Wagenknecht, Lynne E.
Hsu, Fang-Chi
Xu, Jianzhao
Smith, S. Carrie
Palmer, Nicholette D.
Hicks, Pamela J.
Bowden, Donald W.
Register, Thomas C.
Ma, Lijun
Carr, J. Jeffrey
Freedman, Barry I.
FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes
title FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes
title_full FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes
title_fullStr FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes
title_full_unstemmed FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes
title_short FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes
title_sort fgf23 concentration and apol1 genotype are novel predictors of mortality in african americans with type 2 diabetes
topic Cardiovascular and Metabolic Risk
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741152/
https://www.ncbi.nlm.nih.gov/pubmed/29113983
http://dx.doi.org/10.2337/dc17-0820
work_keys_str_mv AT changaryc fgf23concentrationandapol1genotypearenovelpredictorsofmortalityinafricanamericanswithtype2diabetes
AT diversjasmin fgf23concentrationandapol1genotypearenovelpredictorsofmortalityinafricanamericanswithtype2diabetes
AT russellgregoryb fgf23concentrationandapol1genotypearenovelpredictorsofmortalityinafricanamericanswithtype2diabetes
AT langefeldcarld fgf23concentrationandapol1genotypearenovelpredictorsofmortalityinafricanamericanswithtype2diabetes
AT wagenknechtlynnee fgf23concentrationandapol1genotypearenovelpredictorsofmortalityinafricanamericanswithtype2diabetes
AT hsufangchi fgf23concentrationandapol1genotypearenovelpredictorsofmortalityinafricanamericanswithtype2diabetes
AT xujianzhao fgf23concentrationandapol1genotypearenovelpredictorsofmortalityinafricanamericanswithtype2diabetes
AT smithscarrie fgf23concentrationandapol1genotypearenovelpredictorsofmortalityinafricanamericanswithtype2diabetes
AT palmernicholetted fgf23concentrationandapol1genotypearenovelpredictorsofmortalityinafricanamericanswithtype2diabetes
AT hickspamelaj fgf23concentrationandapol1genotypearenovelpredictorsofmortalityinafricanamericanswithtype2diabetes
AT bowdendonaldw fgf23concentrationandapol1genotypearenovelpredictorsofmortalityinafricanamericanswithtype2diabetes
AT registerthomasc fgf23concentrationandapol1genotypearenovelpredictorsofmortalityinafricanamericanswithtype2diabetes
AT malijun fgf23concentrationandapol1genotypearenovelpredictorsofmortalityinafricanamericanswithtype2diabetes
AT carrjjeffrey fgf23concentrationandapol1genotypearenovelpredictorsofmortalityinafricanamericanswithtype2diabetes
AT freedmanbarryi fgf23concentrationandapol1genotypearenovelpredictorsofmortalityinafricanamericanswithtype2diabetes